Suffolk Capital Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-54,063	Closed	-$1.4M	–	124
2017 Q3	$1.4M	Sell	54,063 -181	-0.3%	-$4.67K	0.18%	67
2017 Q2	$1.47M	Buy	+54,244	New	+$1.47M	0.19%	97